loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (DMF) of NCGC00024676-03 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    NCGC00024676-03

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    26/09/2024 Bayer AG
    Germany
    		 BAYER CORP 5905 BAYPRESS R(NITRENDIPINE)TABLETS 5MG.,10MG.AND 20MG. 1985-07-03 Inactive II N/A
    26/09/2024 Bayer AG
    Germany
    		 BAYER CORP 5401 NITRENDIPINE, RAW MATERIAL SUB.(TM:BAYPRESS) 1984-06-18 Inactive II N/A